PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 189 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $452,000 | -83.6% | 9,650 | -82.2% | 0.01% | -84.2% |
Q2 2020 | $2,748,000 | +12.8% | 54,150 | -0.8% | 0.04% | -2.6% |
Q1 2020 | $2,436,000 | -14.0% | 54,600 | -6.6% | 0.04% | +39.3% |
Q4 2019 | $2,832,000 | -5.1% | 58,450 | -33.8% | 0.03% | -15.2% |
Q3 2019 | $2,985,000 | -26.7% | 88,250 | -2.4% | 0.03% | -25.0% |
Q2 2019 | $4,071,000 | +23.9% | 90,450 | +3.6% | 0.04% | +22.2% |
Q1 2019 | $3,286,000 | -31.5% | 87,276 | -37.5% | 0.04% | -41.9% |
Q4 2018 | $4,797,000 | -27.0% | 139,750 | 0.0% | 0.06% | -1.6% |
Q3 2018 | $6,568,000 | -7.3% | 139,750 | -33.5% | 0.06% | -10.0% |
Q2 2018 | $7,084,000 | +24.7% | 210,007 | 0.0% | 0.07% | +20.7% |
Q1 2018 | $5,683,000 | +54.3% | 210,007 | -4.9% | 0.06% | +65.7% |
Q4 2017 | $3,683,000 | -19.7% | 220,818 | -3.7% | 0.04% | -5.4% |
Q3 2017 | $4,589,000 | +6.6% | 229,338 | -2.3% | 0.04% | 0.0% |
Q2 2017 | $4,305,000 | +86.3% | 234,835 | 0.0% | 0.04% | +85.0% |
Q1 2017 | $2,311,000 | -6.0% | 234,835 | +4.2% | 0.02% | 0.0% |
Q4 2016 | $2,459,000 | -22.1% | 225,367 | 0.0% | 0.02% | -20.0% |
Q3 2016 | $3,157,000 | +105.1% | 225,367 | +2.8% | 0.02% | +92.3% |
Q2 2016 | $1,539,000 | – | 219,206 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |